NIH Reporter #5K01DK140610-02

Research Grant for Mitochondrial Metabolism in Human Intestinal Stem Cells (NIDDK/UNC Chapel Hill)

This opportunity is a research grant solicitation from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in partnership with the University of North Carolina Chapel Hill's Department of Biomedical Engineering, focused on mitochondrial metabolism in human intestinal stem cells. - Government Buyer: - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Collaboration with University of North Carolina Chapel Hill, Department of Biomedical Engineering - Products/Services Requested: - Research funding for studies on transcriptional regulation of mitochondrial metabolism in human intestinal stem cells, with emphasis on inflammatory bowel disease - NAICS codes: 541712 (Biotechnology R&D), 541713 (Nanotechnology R&D) - OEMs and Vendors: - No specific OEMs or commercial vendors are named, as this is a grant for academic research - Unique/Notable Requirements: - Focus on advanced biotechnology and nanotechnology research - Collaboration between NIH and UNC Chapel Hill - Project targets a specific area of biomedical research with potential impact on inflammatory bowel disease - Grant application guidelines provided as an attachment

Description

This is a research grant opportunity focused on transcriptional regulation of mitochondrial function in human intestinal stem cells, with a focus on inflammatory bowel disease. The project involves collaboration between UNC Chapel Hill and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The solicitation is open and active, with a response deadline of January 15, 2024. The funding supports research and development in biotechnology and nanotechnology.

View original listing